Peptides as tools in drug discovery.

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• The post-genomics era presents both opportunities and challenges in drug discovery.
• Identifying effective therapeutics necessitates optimized target selection, assay development, screening, and compound follow-up.
• New tools and techniques are crucial for efficiently advancing potential drug targets through the discovery pipeline.

Purpose of the Study:

• To review the application of peptide ligands in drug discovery.
• To demonstrate how peptide ligands can validate target sites, assist structure-based design, and enable high-throughput screening.
• To present an integrated discovery program paradigm for accelerated target-to-lead progression.

Main Methods:

• Utilizing peptide ligands to target specific functional sites on candidate proteins.
• Employing peptide ligands for target site validation and structure-based drug design.
• Developing robust, sensitive high-throughput screening assays using peptide ligands to identify modulators of protein function.

Main Results:

• Peptide ligands facilitate the validation of protein target sites.
• They aid in structure-based design programs for therapeutic development.
• Peptide ligands enable the creation of sensitive high-throughput screens for compound identification.

Conclusions:

• An integrated drug discovery program combining peptide ligands with other methods offers a new paradigm.
• This approach allows for rapid, parallel progression of multiple targets from initial choice to lead identification.
• Peptide ligands are versatile tools for enhancing efficiency and success in modern drug discovery.